CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
CRI Immuno-Informatics Postdoctoral Fellowship supports early-career scientists worldwide with research and training linking immunology and data science to advance cancer immunotherapy.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
The CRI Irvington Postdoctoral Fellowship Program supports early-career scientists in immunology and cancer immunology research, fostering innovation and leadership through funding and mentorship from the Cancer Research Institute.